Fundraising FoxMindMed
2 known investors
Find your way into MindMed
Sign up to see every warm intro you have to MindMed
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MindMed team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Definium Therapeutics is a biotech company developing psychedelic-based treatments for brain health disorders, including formulations of LSD and MDMA enantiomers targeting depression, anxiety, PTSD, and autism spectrum disorder. Its pipeline focuses on psychiatric and neurological conditions affecting patients in the U.S.
Investors · 2
Acquisitions · 1
Early investors' stakes continue via these dealsHealthMode
HealthMode was a San Francisco AI-driven digital health startup that built a platform using machine learning to automate and improve precision of patient monitoring during clinical drug trials.
Frequently asked questions
- What does MindMed do?
- Definium Therapeutics is a biotech company developing psychedelic-based treatments for brain health disorders, including formulations of LSD and MDMA enantiomers targeting depression, anxiety, PTSD, and autism spectrum disorder. Its pipeline focuses on psychiatric and neurological conditions affecting patients in the U.S.
- Who are MindMed's investors?
- MindMed's investors include Noetic, Seven Hound Ventures.